Broadbill Pharma India Private Limited
About Broadbill Pharma India Private Limited
Data last updated:
Broadbill Pharma India Private Limited was a private limited company based in Ghaziabad, Uttar Pradesh, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 February 2015.
The company was registered with the Registrar of Companies (ROC), Kanpur, under CIN U24233UP2015PTC068999.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Hema Tyagi and Vandana Umesh Bhilare.
Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at Ghaziabad, Uttar Pradesh.
Company details
Contact details
Broadbill Pharma India Private Limited's registered office is in Ghaziabad, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No.791 New Arya Nagar Opposite Ram Krishan Institute Delhi – Me, Erut Road, Ghaziabad, Uttar Pradesh, India – 201001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Broadbill Pharma India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Broadbill Pharma India Private Limited
FY 2018 filings availableFinancial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ||||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ||||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Broadbill Pharma India Private Limited, buy the company report.
Board of directors of Broadbill Pharma India Private Limited
Broadbill Pharma India has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vandana Umesh Bhilare | Additional Director | 30 Jun 2017 | 9 Years 4 Months | As last reported |
| Hema Tyagi | Director | 18 Feb 2015 | 11 Years 8 Months | As last reported |
Auditor
Broadbill Pharma India Private Limited is audited by SHASHI KAMAL & ASSOCIATES for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHASHI KAMAL & ASSOCIATES | FY 2018 | 003826C |
Shareholding
The shareholding of Broadbill Pharma India Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Broadbill Pharma India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Broadbill Pharma India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Broadbill Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Broadbill Pharma India Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Broadbill Pharma India Private Limited has 4 board changes on record since 2015: 2 appointments and 2 cessations. The latest: Pooja Batham ceased to be Additional Director on 01 Jun 2019.
Frequently asked questions
Broadbill Pharma India has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Broadbill Pharma India was a private limited company based in Ghaziabad, Uttar Pradesh, India. The company worked in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 February 2015 and is registered under CIN U24233UP2015PTC068999. The company has been struck off by the Registrar of Companies and is no longer operational.
Broadbill Pharma India had 2 directors:
- Vandana Umesh Bhilare - Additional Director
- Hema Tyagi - Director
The CIN (Corporate Identification Number) of Broadbill Pharma India is U24233UP2015PTC068999. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Broadbill Pharma India is at House No.791 New Arya Nagar Opposite Ram Krishan Institute Delhi – Me, Erut Road, Ghaziabad, Uttar Pradesh, India – 201001.
Broadbill Pharma India was incorporated on 18 February 2015. It is registered with the Registrar of Companies, Kanpur.
The latest financial statements of Broadbill Pharma India on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 29 September 2018. Year-wise statements from 2015 are in the company report.
Broadbill Pharma India operated in the pharma industry, in the pharmaceutical retailers and distributors segment. It worked in this industry before it was struck off.
Pooja Batham ceased to be Additional Director on 01 Jun 2019. Tarun Tyagi ceased to be Director on 30 Jun 2017. Vandana Umesh Bhilare was appointed as Additional Director on 30 Jun 2017. Broadbill Pharma India has 4 board changes on record in total.
The compliance status of Broadbill Pharma India is compliant as of 19 September 2026.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
